CORTERIA PHARMACEUTICALS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)CRF2 Agonist for the Treatment of Worsening Heart Failure
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Corteria Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT06815471
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
Completed
- Conditions
- Heart FailureHeart Decompensation
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Corteria Pharmaceuticals
- Target Recruit Count
- 42
- Registration Number
- NCT05747820
- Locations
- 🇦🇲
Institute of Cardiology Levon Hovhannisyan, Yerevan, Armenia
🇦🇲Erebuni Medical Center, Yerevan, Armenia
🇧🇦Health Institution Medico Laser, Cardiology ward, Banja Luka, Bosnia and Herzegovina
News
No news found